Timing underpins the benefits associated with injectable collagen biomaterial therapy for the treatment of myocardial infarctionNick J. R. Blackburn, Erik J. Suuronen, Tanja Sofrenovic et al.|Biomaterials|2014Cited by 101
The role of integrin α2 in cell and matrix therapy that improves perfusion, viability and function of infarcted myocardiumAli Ahmadi, Erik J. Suuronen, Brian McNeill et al.|Biomaterials|2014Cited by 39
<sup>18</sup> F-FDG Cell Labeling May Underestimate Transplanted Cell Homing: More Accurate, Efficient, and Stable Cell Labeling with Hexadecyl-4-[ <sup>18</sup> F]Fluorobenzoate for in Vivo Tracking of Transplanted Human Progenitor Cells by Positron Emission TomographyYan Zhang, Marc Ruel, Jean N. DaSilva et al.|Cell Transplantation|2012Cited by 36
Preclinical Evaluation of Biopolymer-Delivered Circulating Angiogenic Cells in a Swine Model of Hibernating MyocardiumCéline Giordano, Marc Ruel, Stephanie Thorn et al.|Circulation Cardiovascular Imaging|2013Cited by 12
Development of reporter gene imaging techniques for long-term assessment of human circulating angiogenic cellsYan Zhang, Erik J. Suuronen, Drew Kuraitis et al.|Biomedical Materials|2015Cited by 1